Pemetrexed is a chemotherapeutic agent used primarily in the treatment of non-small cell lung cancer and malignant pleural mesothelioma. It is a folate analog metabolic inhibitor that disrupts crucial folate-dependent metabolic processes necessary for cell replication.
